Since NKp30 plays a crucial role in NK-cell activation and tumor surveillance, the increased expression of its cognate ligand B7-H6 by chemotherapeutics enhances NK cell-mediated ADCC against tumor cells [43]. The gene discussed is NCR3; the disease is neoplasm.